CAV1 and Parkinson disease: Loss or reduction of cav-1 expression in a mouse model of HD suppresses the motor phenotype [60], suggesting that cav-1 is a critical factor for neurodegeneration and could be a novel therapeutic target for many neurodegenerative diseases including PD.